A study revealed that Arimidex reduced the risk of breast cancer by 53% among postmenopausal women, who are at high risk for the disease. It is a medication used to treat breast cancer in women who no longer have their periods.
The medicine contains Anastrozole, an extremely potent anti-estrogen in the aromatase family. It is proven to be extremely effective in treating breast cancer, even more than the traditional drug Tamoxifen citrate.
Arimidex is the most common anti-estrogen available on the market. Anastrozole 1mg is a hormonal therapy that lowers estrogen levels in postmenopausal women to slow down the growth of cancerous cells in the breast. The active ingredient of the medicine works by inhibiting the enzyme aromatase, thereby reducing estrogen production.
Arimidex- A new way to approach breast cancer
Arimidex is a chemo drug mainly prescribed to treat breast cancer in postmenopausal women. It is a first-line chemotherapy treatment and is helpful for patients with an advanced stage of breast cancer. It is specifically given to women who have been diagnosed with breast cancer and have not had any effect on the growth of breast cancer cells after taking Tamoxifen (an anticancer agent).
Breast cancer usually carries symptoms such as thickening of breast tissue, a lump in the breast, nipple discharge, rashes, and swelling. According to research studies, women who took anastrozole daily for five years halved their risk of developing breast cancer. The results are promising; the risk and benefits balance in the long term.
Arimidex for early breast cancer
An aromatase inhibitor like Anastrozole is approved for treating women with breast cancer that has not spread to other parts of the body. The drug may also be given after 2 to 3 years of Tamoxifen, as according to research studies, switching may be better for some women. An aromatase inhibitor is also taken if you cannot take tamoxifen due to potential side effects.
Good evidence in the advanced stage
Arimidex 1mg may also work in the condition when the growth of cancer cells reoccurs in the breast. It may also be prescribed to treat cancer which has spread to other parts of the body while you are still using Tamoxifen or another anti-estrogen hormone. A patient with this condition must continue taking Anastrozole preparation for as long as her breast cancer remains under control.
Anastrozole Goal- To stop cancer growth
The estrogen hormone is believed to fuel the growth of breast cancer. After women go through menopause, their ovaries stop producing estrogen, and an enzyme called aromatase starts producing the hormone. Aromatase is present in fatty tissues, such as breast tissue. Our anticancer drug Arimidex contains Anastrozole, an aromatase inhibitor. It blocks the aromatase enzyme, lowering estrogen levels in the bodies of postmenopausal women. The active pharmaceutical agent shows promising results for preventing breast cancer.
A positive balance of risks and benefits with Arimidex 1 mg
Like other treatments, this hormonal treatment is also not free from side effects. In research studies, patients who used Anastrozole experienced night sweats, hot flushes, and joint pain. There have also been concerns that Arimidex 1mg could reduce bone density. But it is possible to manage the impact of the drug on women’s bones.
Take Arimidex to control cancer growth
Arimidex comes in the form of a 1mg tablet that you take once daily to prevent cancer growth. Consider taking it at the same time every day. Avoid missing a dose. If you miss, don’t take an extra one on the same day to enhance the benefits.
If you are diagnosed with early breast cancer, you will need to take an Anastrozole tablet for five years. In some cases, the doctor may tell you to switch to Arimidex after 2 to 3 years of taking another anticancer drug, Tamoxifen, and finish up after a total of 5 years.
Taking an extra dose will only cause side effects, which can be dangerous. Do not discontinue treatment unless your doctor tells you to. Keep the medicine out of reach of children at room temperature, away from light and heat.
Precautions
If you are hypersensitive to Anastrozole, the active constituent of your anticancer drug, you should avoid taking it and inform your doctor about it. Having pre-existing health complications such as blood circulation issues, blood clots, kidney disease, liver impairment, incomplete menopause, or any heart condition requires a doctor’s consultation. Also, a patient must notify her doctor about other estrogen-based medications, as they may interact with Anastrozole and cause side effects. Inform your doctor about your current pregnancy status as the anticancer drug may cause harm to unborn and newborn babies.
